127 related articles for article (PubMed ID: 37466579)
1. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
[TBL] [Abstract][Full Text] [Related]
2. Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
Zeitlinger L; Wilson M; Randall RL; Thorpe S;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):79-86. PubMed ID: 37466584
[TBL] [Abstract][Full Text] [Related]
3. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
Jackson KJ; Sullivan CD; Zimel MN; Wustrack RL;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):49-56. PubMed ID: 37466580
[TBL] [Abstract][Full Text] [Related]
4. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for All-Cause Early Reoperation Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis from the PARITY Trial.
Kendal JK; Slawaska-Eng D; Gazendam A; Schneider P; Wessel LE; Ghert M; Bernthal NM;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):4-9. PubMed ID: 37466573
[TBL] [Abstract][Full Text] [Related]
7. Does the Use of Negative Pressure Wound Therapy and Postoperative Drains Impact the Development of Surgical Site Infections?: A PARITY Trial Secondary Analysis.
LiBrizzi CL; Sabharwal S; Forsberg JA; Leddy L; Doung YC; Morris CD; Levin AS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):34-40. PubMed ID: 37466578
[TBL] [Abstract][Full Text] [Related]
8. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
[TBL] [Abstract][Full Text] [Related]
9. Central Adjudication Committee and Clinical Site Investigator Agreement on Outcomes in the PARITY Trial: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Giglio V; Gazendam AM; Schneider P; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):73-78. PubMed ID: 37466583
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
; Ghert M; Schneider P; Guyatt G; Thabane L; Vélez R; O'Shea T; Randall RL; Turcotte R; Wilson D; Wunder JS; Baptista AM; Cheng EY; Doung YC; Ferguson PC; Giglio V; Hayden J; Heels-Ansdell D; Khan SA; Sampath Kumar V; McKay P; Miller B; van de Sande M; Zumárraga JP; Bhandari M
JAMA Oncol; 2022 Mar; 8(3):345-353. PubMed ID: 34989778
[TBL] [Abstract][Full Text] [Related]
11. Surgical site infections after lower extremity revascularization procedures involving groin incisions.
Kuy S; Dua A; Desai S; Dua A; Patel B; Tondravi N; Seabrook GR; Brown KR; Lewis BD; Lee CJ; Kuy S; Subbarayan R; Rossi PJ
Ann Vasc Surg; 2014 Jan; 28(1):53-8. PubMed ID: 24189008
[TBL] [Abstract][Full Text] [Related]
12. The association between preoperative length of stay and surgical site infection after lower extremity bypass for chronic limb-threatening ischemia.
Stewart LM; Spangler EL; Sutzko DC; Pearce BJ; McFarland GE; Passman MA; Patterson MA; Haverstock B; Unger K; Novak Z; Beck AW
J Vasc Surg; 2021 Apr; 73(4):1340-1349.e2. PubMed ID: 32889070
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?
Gazendam AM; Schneider P; Spiguel A; Ghert M
Ann Surg Oncol; 2022 Nov; 29(12):7312-7317. PubMed ID: 35864365
[TBL] [Abstract][Full Text] [Related]
14. Intracavity lavage and wound irrigation for prevention of surgical site infection.
Norman G; Atkinson RA; Smith TA; Rowlands C; Rithalia AD; Crosbie EJ; Dumville JC
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012234. PubMed ID: 29083473
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.
Gallagher M; Jones DJ; Bell-Syer SV
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005360. PubMed ID: 31557310
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Functional Recovery among Musculoskeletal Oncology Patients Undergoing Lower Extremity Endoprosthetic Reconstruction.
Gazendam AM; Schneider P; Heels-Ansdell D; Bhandari M; Busse JW; Ghert M
Curr Oncol; 2022 Oct; 29(10):7598-7606. PubMed ID: 36290877
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and Risk Factors for Thromboembolism After Endoprosthetic Reconstruction in Musculoskeletal Oncology Patients.
Sabharwal S; LiBrizzi CL; Forsberg JA; Morris CD; Levin AS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):29-33. PubMed ID: 37466577
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Implant Fixation Type on Reoperation Rates Following Endoprosthetic Reconstruction Surgery.
Giglio V; Gazendam A; Schneider P; Ghert M; Wilson D;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):15-21. PubMed ID: 37466575
[TBL] [Abstract][Full Text] [Related]
19. Opioid Use in Surgical Management in Musculoskeletal Oncology.
Gazendam AM; Ghert M; Gundle KR; Hayden JB; Doung YC;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):10-14. PubMed ID: 37466574
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial of negative pressure wound therapy for high-risk groin wounds in lower extremity revascularization.
Lee K; Murphy PB; Ingves MV; Duncan A; DeRose G; Dubois L; Forbes TL; Power A
J Vasc Surg; 2017 Dec; 66(6):1814-1819. PubMed ID: 28865981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
